Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ILMN vs GSK✓SelectedUSD · GSKILMN vs GSK performance historyLatest closeAs of-4.35%11/16
Stock and ETF performance explorer

ILMN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.9%
GSK return
+9.7%
Excess return
+55.2%
Maximum drawdown
-32.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.4%-0.1%-4.3%-4.4%
7D-10.3%-1.3%-9.0%-10.3%
30D-24.6%+2.7%-27.3%-24.5%
3M+3.7%+2.7%+1.0%+3.9%
6M+38.9%+3.3%+35.6%+38.2%
YTD+51.0%+6.5%+44.5%+49.0%
All+64.9%+9.7%+55.2%+60.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling